Everest Medicines Limited (HKG: 1952)
Hong Kong
· Delayed Price · Currency is HKD
46.70
-0.15 (-0.32%)
Dec 20, 2024, 11:53 AM HKT
Everest Medicines Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 |
---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 |
Cash & Equivalents | - | 523.06 | 490.79 | 2,640 | 4,481 | 106.06 | Upgrade
|
Short-Term Investments | - | 1,827 | 1,161 | - | 2.08 | 0.16 | Upgrade
|
Cash & Short-Term Investments | - | 2,350 | 1,651 | 2,640 | 4,483 | 106.22 | Upgrade
|
Cash Growth | - | 42.29% | -37.45% | -41.11% | 4120.60% | -42.24% | Upgrade
|
Accounts Receivable | - | 49.86 | 5.21 | 0.05 | - | - | Upgrade
|
Other Receivables | - | 81.96 | 1,681 | 19.52 | 10.91 | 22.56 | Upgrade
|
Receivables | - | 131.81 | 1,687 | 19.57 | 10.91 | 22.56 | Upgrade
|
Inventory | - | 18.94 | 11.64 | 0.45 | - | - | Upgrade
|
Other Current Assets | - | 7.16 | 64.6 | 27.86 | 2.3 | 2.37 | Upgrade
|
Total Current Assets | - | 2,508 | 3,414 | 2,688 | 4,496 | 131.15 | Upgrade
|
Property, Plant & Equipment | - | 683.99 | 643.86 | 262.64 | 121.97 | 46.08 | Upgrade
|
Long-Term Investments | - | 48.93 | 89.24 | 830.4 | 845.7 | 34.88 | Upgrade
|
Other Intangible Assets | - | 2,524 | 2,378 | 2,471 | 2,006 | 1,663 | Upgrade
|
Other Long-Term Assets | - | 6.12 | 86.69 | 391.44 | 4.87 | 261.38 | Upgrade
|
Total Assets | - | 5,773 | 6,615 | 6,646 | 7,477 | 2,137 | Upgrade
|
Accounts Payable | - | 95.48 | 107.52 | 85.66 | 75.1 | 40.32 | Upgrade
|
Accrued Expenses | - | 73.51 | 182.07 | 133.79 | 87.62 | 51.39 | Upgrade
|
Short-Term Debt | - | - | - | - | - | 279.05 | Upgrade
|
Current Portion of Long-Term Debt | - | 22.66 | 424.08 | - | - | - | Upgrade
|
Current Portion of Leases | - | 18.65 | 20.33 | 28.25 | 19.02 | 10.54 | Upgrade
|
Other Current Liabilities | - | 89.82 | 136.03 | 22.56 | 5.18 | 122.57 | Upgrade
|
Total Current Liabilities | - | 300.13 | 870.03 | 270.27 | 186.91 | 503.87 | Upgrade
|
Long-Term Debt | - | 457.93 | 30.92 | 387.71 | 390.32 | 2,464 | Upgrade
|
Long-Term Leases | - | 40 | 59.31 | 95.85 | 58.88 | 30.22 | Upgrade
|
Long-Term Unearned Revenue | - | 6.05 | - | - | - | - | Upgrade
|
Total Liabilities | - | 804.1 | 960.26 | 753.83 | 636.11 | 2,998 | Upgrade
|
Common Stock | - | 0.22 | 0.21 | 0.2 | 0.2 | 0.02 | Upgrade
|
Retained Earnings | - | -9,016 | -8,172 | -7,925 | -6,916 | -1,258 | Upgrade
|
Treasury Stock | - | -0 | -0 | -58.71 | - | - | Upgrade
|
Comprehensive Income & Other | - | 13,985 | 13,826 | 13,875 | 13,757 | 396.75 | Upgrade
|
Shareholders' Equity | - | 4,969 | 5,654 | 5,892 | 6,841 | -861.08 | Upgrade
|
Total Liabilities & Equity | - | 5,773 | 6,615 | 6,646 | 7,477 | 2,137 | Upgrade
|
Total Debt | - | 539.24 | 534.64 | 511.81 | 468.21 | 2,784 | Upgrade
|
Net Cash (Debt) | - | 1,810 | 1,117 | 2,128 | 4,015 | -2,678 | Upgrade
|
Net Cash Growth | - | 62.12% | -47.53% | -46.99% | - | - | Upgrade
|
Net Cash Per Share | - | 5.78 | 3.75 | 7.26 | 47.04 | -512.23 | Upgrade
|
Filing Date Shares Outstanding | - | 319.36 | 305.46 | 294.41 | 293.22 | 25.03 | Upgrade
|
Total Common Shares Outstanding | - | 319.36 | 305.46 | 294.41 | 293.22 | 25.03 | Upgrade
|
Working Capital | - | 2,207 | 2,544 | 2,418 | 4,309 | -372.72 | Upgrade
|
Book Value Per Share | - | 15.56 | 18.51 | 20.01 | 23.33 | -34.41 | Upgrade
|
Tangible Book Value | - | 2,445 | 3,276 | 3,421 | 4,835 | -2,525 | Upgrade
|
Tangible Book Value Per Share | - | 7.66 | 10.72 | 11.62 | 16.49 | -100.88 | Upgrade
|
Buildings | - | 437.87 | 378.28 | - | - | - | Upgrade
|
Machinery | - | 167.32 | 84.66 | 5.72 | 1.65 | 1.69 | Upgrade
|
Construction In Progress | - | 9.79 | 45.75 | 102.91 | 5.92 | - | Upgrade
|
Leasehold Improvements | - | 46.9 | 44.77 | 15.91 | 9.98 | 7.9 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.